RPSE Res.Phm.Reg S

    RNS Number : 9452U
  Research Pharmaceutical SRV, Inc
  21 May 2008
   

    21 May 2008

    ReSearch Pharmaceutical Services Inc.

    Exercise of Options

    ReSearch Pharmaceutical Services, Inc. (the "Company"), a leading provider of clinical development outsourcing solutions to the
biopharmaceutical industry, announces today the issue of 5,018 new shares of common stock of $0.0001 each ("Shares") relating to the
exercise of outstanding employee share options at an average exercise price of $0.83 per Share.

    Application has been made for the admission to trading on AIM of 5,018 new Shares and dealings in the new Shares are expected to
commence on May 22, 2008.  The new Shares rank pari passu with the Company's existing issued Shares.

    Following this issue, the Company will have outstanding 32,547,406 Shares and 1,357,179 Warrants (as defined in the Company's
Readmission Document dated June 5, 2007)(1).

    (1)    These figures exclude the remaining 186,667 Unit Purchase Options and approximately 2.8
             million employee stock options which also remain outstanding.

    For further information please contact:

    ReSearch Pharmaceutical Services, Inc.:                            +1-215-540-0700
    Daniel M. Perlman, Chairman & Chief Executive Officer
    Steven Bell, Chief Financial Officer

    Nominated Adviser and UK Broker:                                       +44-20-7012-2100
    Arbuthnot Securities Limited
    James Steel/Richard Tulloch


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
IOEABMPTMMTTMIP

Res.Phm.Reg S (LSE:RPSE)
Historical Stock Chart
From May 2024 to May 2024

Res.Phm.Reg S (LSE:RPSE)
Historical Stock Chart
From May 2023 to May 2024